PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Enveric Biosciences Canada Inc.

USPTO PatentsView assignee record - 23 granted patents across 11 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (HETEROCYCLIC COMPOUNDS).

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Enveric ranks #12,912 of 50,000 tracked US assignees by granted-patent volume, with 23 patents across 11 technology areas.

#12,912
of 50,000 US assignees by volume
Top 6%
by Innovation Score (55.9/100)
22.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R12912 · Foreign Corporation #12,912 · 23 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 23 grants
  • MID-PACK #12,912/50,000
  • PHOTO-FINISH Edscha Engineering
  • CPC-FOCUS C07D · 11 areas
  • INNOV-PAR 55.9/100
  • CLAIMS-DENSE 22.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2023–2025 · 3y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Edscha Engineering Gmbh (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Enveric

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Enveric Biosciences Canada Inc. stamps GRANTS-SMALL, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-DENSE, TYPE-FRNCORP, SPAN-YRS, BOOK-RICH. Volume places it #12,912 of 50,000; Innovation Score 55.9/100 sits in the top 6% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Edscha Engineering Gmbh (±0 grants).

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Portfolio overview

Enveric Biosciences Canada Inc. has been granted 23 US utility patents between 2023 and 2025, placing Enveric Biosciences Canada Inc. at #12,912 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.0 claims per patent with primary concentration in C07D (HETEROCYCLIC COMPOUNDS). As a Foreign Corporation, Enveric Biosciences Canada Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Enveric sits between Edscha Engineering Gmbh (23 patents, rank #12,909) and Federal-mogul Valvetrain Gmbh (23 patents, rank #12,917) - the closest US assignees by grant volume. The composite Innovation Score of 55.9/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Historical data spans 2023 through 2025, with 23 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Enveric Biosciences Canada Inc.'s 22.0 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 11 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at Enveric's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Enveric holds 23 patents at rank #12,913, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Enveric

By rank, the assignees closest to #12,913 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Enveric's primary technology class.

Enveric's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 6% higher than 94% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

468101214 202320242025 6
USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table
Enveric Biosciences Canada Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2023 5 21.7%
2024 12 52.2%
2025partial year 6 26.1%

Which technologies does Enveric Biosciences Canada Inc. patent most?

Top 11 of 11 technology areas

Where it ranks

Overall rank by patents

#12,912

of 50,000 tracked assignees

Innovation Score

55.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?
Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.